SBRT2015

SBRT for pancreatic cancer

CONCLUSIONS

• Small patient numbers treated in prospective

trials

• Local tumor control appears favourable

• Very limited overall survival, similar to Cx only

• High rates of severe GI toxicity



Should not be practiced outside of

prospective trials

ESTRO SBRT Course 2014 - Emerging SBRT indications